8 Results

People

  1. Lal
    Lal
  2. Chen
    Chen
  3. Bhargava
    Bhargava
  4. Ladanyi
    Ladanyi
  5. Gerald
    Gerald
  6. Hudis
    Hudis
  7. Salazar
    Salazar
  8. Danso
    Danso
  9. Doane
    Doane
  10. Donaton
    Donaton

Groups

  1. GSK Faculty (3)
  2. Human Oncology and Pathogenesis Program (3)
  3. Tow Center for Developmental Oncology (TCDO) (3)
  4. Breast Medicine Service (2)
  5. Department of Medicine (2)
  6. Solid Tumor Oncology Division (2)
  7. Survivorship Research (2)
  8. MSK Grad Students (1)
  1. "breast neoplasms"
  2. "Priti Lal"
Formats
  1. Journal Article (8)
Groups
  1. GSK Faculty (3)
  2. Human Oncology and Pathogenesis Program (3)
  3. Tow Center for Developmental Oncology (TCDO) (3)
  4. Breast Medicine Service (2)
  5. Department of Medicine (2)
  6. Solid Tumor Oncology Division (2)

More Groups

People
  1. Priti Lal (8)
  2. Beiyun Chen (7)
  3. Rohit Bhargava (4)
  4. Marc Ladanyi (3)
  5. Clifford Hudis (2)
  6. Paulo Salazar (2)

More People

Years
  1. 2006 (1)
  2. 2005 (4)
  3. 2004 (2)
  4. 2003 (1)
Publications
  1. American Journal of Clinical Pathology (4)
  2. Diagnostic Molecular Pathology (1)
  3. Journal of Molecular Diagnostics (1)
  4. Modern Pathology (1)
  5. Oncogene (1)
Publishers
  1. Oxford University Press (4)
  2. Elsevier Science, Inc. (1)
  3. Lippincott Williams & Wilkins (1)
  4. Nature Publishing Group (1)
  5. Nature Research (1)

Results (8)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen
    Journal Article

    Doane, A. S.; Danso, M.; Lal, P.; Donaton, M.; Zhang, L.; Hudis, C.; Gerald, W. L.
    Oncogene (2006)

    Fulltext@MSK | Save
  • Correlation of HER-2 status with estrogen and progesterone receptors and histologic features in 3,655 invasive breast carcinomas
    Journal Article

    Lal, P.; Tan, L. K.; Chen, B.
    American Journal of Clinical Pathology (2005)

    Fulltext@MSK | Save
  • Chromogenic in situ hybridization for the detection of HER-2/neu gene amplification in breast cancer with an emphasis on tumors with borderline and low-level amplification: Does it measure up to fluorescence in situ hybridization?
    Journal Article

    Bhargava, R.; Lal, P.; Chen, B.
    American Journal of Clinical Pathology (2005)

    Fulltext@MSK | Save
  • HER-2/neu and topoisomerase IIα gene amplification and protein expression in invasive breast carcinomas: Chromogenic in situ hybridization and immunohistochemical analyses
    Journal Article

    Bhargava, R.; Lal, P.; Chen, B.
    American Journal of Clinical Pathology (2005)

    Fulltext@MSK | Save
  • EGFR gene amplification in breast cancer: Correlation with epidermal growth factor receptor mRNA and protein expression and HER-2 status and absence of EGFR-activating mutations
    Journal Article

    Bhargava, R.; Gerald, W. L.; Li, A. R.; Pan, Q.; Lal, P.; Ladanyi, M.; Chen, B.
    Modern Pathology (2005)

    Fulltext@MSK | Save
  • HER-2 testing in breast cancer using immunohistochemical analysis and fluorescence in situ hybridization: A single-institution experience of 2,279 cases and comparison of dual-color and single-color scoring
    Journal Article

    Lal, P.; Salazar, P. A.; Hudis, C. A.; Ladanyi, M.; Chen, B.
    American Journal of Clinical Pathology (2004)

    Fulltext@MSK | Save
  • Feasibility of using tissue microarrays for the assessment of HER-2 gene amplification by fluorescence in situ hybridization in breast carcinoma
    Journal Article

    Bhargava, R.; Lal, P.; Chen, B.
    Diagnostic Molecular Pathology (2004)

    Fulltext@MSK | Save
  • Impact of polysomy 17 on Her-2/neu immunohistochemistry in breast carcinomas without Her-2/neu gene amplification
    Journal Article

    Lal, P.; Salazar, P. A.; Ladanyi, M.; Chen, B.
    Journal of Molecular Diagnostics (2003)

    Fulltext@MSK | Save